BioScrip Inc (BIOS)’s Bullish Wedge Up Chart Pattern Points to Lower Stock Risks

September 17, 2017 - By Kurt Siggers

Investors sentiment decreased to 0.89 in 2016 Q4. Its down 0.57, from 1.46 in 2016Q3. It turned negative, as 18 investors sold BioScrip Inc shares while 29 reduced holdings. 16 funds opened positions while 26 raised stakes. 91.55 million shares or 0.99% less from 92.47 million shares in 2016Q3 were reported.
Bridgeway Cap Mngmt reported 55,638 shares. Bnp Paribas Arbitrage has 0% invested in BioScrip Inc (NASDAQ:BIOS) for 12,926 shares. Principal Fincl Gru Incorporated invested in 0% or 27,682 shares. Menta Capital Ltd owns 274,764 shares. Pinnacle Assocs owns 19,500 shares for 0% of their portfolio. The Massachusetts-based State Street Corp has invested 0% in BioScrip Inc (NASDAQ:BIOS). California State Teachers Retirement Sys accumulated 0% or 231,510 shares. 340,429 were reported by Hawk Ridge Cap Management Ltd Partnership. Boothbay Fund Mngmt Lc reported 36,455 shares. Legal & General Grp Public Limited Com reported 27,469 shares stake. Millennium Mngmt Limited Liability Corporation stated it has 0% in BioScrip Inc (NASDAQ:BIOS). Sei Com stated it has 243 shares or 0% of all its holdings. Sheets Smith Wealth Management owns 0.02% invested in BioScrip Inc (NASDAQ:BIOS) for 82,510 shares. Fmr Ltd Liability holds 0% in BioScrip Inc (NASDAQ:BIOS) or 3.53 million shares. Continental Advisors Ltd Liability Corp holds 0.06% or 217,500 shares.

The stock of BioScrip Inc (BIOS) formed an up wedge with $2.80 target or 5.00 % above today’s $2.67 share price. The 7 months wedge indicates low risk for the $340.36 million company. If the $2.80 price target is reached, the company will be worth $17.02M more.
Rising wedges, especially for downward breakouts are tricky moments to trade. Investors must be aware that the break even failure rate for up or down breakouts is: 8% and 24%. The average rise is 28% and the decline is 14%. Wedges has high throwback and pullback rate: 73%, 63% and the percent of wedges meeting target is not more than 50%.

The stock increased 0.38% or $0.01 on September 15, reaching $2.67. About 1.34M shares traded. BioScrip Inc (NASDAQ:BIOS) has declined 29.17% since September 17, 2016 and is downtrending. It has underperformed by 45.87% the S&P500.

Analysts await BioScrip Inc (NASDAQ:BIOS) to report earnings on November, 6. They expect $-0.10 earnings per share, 0.00 % or $0.00 from last year’s $-0.1 per share. After $-0.11 actual earnings per share reported by BioScrip Inc for the previous quarter, Wall Street now forecasts -9.09 % EPS growth.

BioScrip Inc (NASDAQ:BIOS) Ratings Coverage

Among 6 analysts covering BioScrip (NASDAQ:BIOS), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioScrip had 10 analyst reports since August 11, 2015 according to SRatingsIntel. Lake Street initiated BioScrip Inc (NASDAQ:BIOS) rating on Tuesday, January 3. Lake Street has “Buy” rating and $4.50 target. Jefferies maintained BioScrip Inc (NASDAQ:BIOS) rating on Thursday, June 8. Jefferies has “Buy” rating and $300 target. The stock of BioScrip Inc (NASDAQ:BIOS) earned “Buy” rating by Jefferies on Wednesday, August 9. The rating was maintained by Jefferies on Tuesday, July 25 with “Buy”. The stock has “Buy” rating by SunTrust on Tuesday, August 11. The stock of BioScrip Inc (NASDAQ:BIOS) has “Buy” rating given on Wednesday, August 12 by Dougherty & Company. The rating was upgraded by SunTrust to “Buy” on Thursday, August 10.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.